Reducing the risk of end-stage complications of neovascular age-related macular degeneration (AMD): macular atrophy and subretinal fibrosis
Read MoreReducing the risk of end-stage complications of neovascular age-related macular degeneration (AMD): macular atrophy and subretinal fibrosis
Read MoreTowards a personalised approach to predicting and preventing progression of age-related macular degeneration
Read MoreGenotype-phenotype correlations in PRPH2-associated retinal dystrophy
Read MoreNocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration
Read MoreMacular vascular disease: software standardisation and data harmonisation to accelerate the development of new imaging biomarkers and therapies
Read MoreNext-generation gene therapy for Stargardt Disease: Enhanced AAV-mediated ABCA4 delivery to restore vision
Read MoreWelcome to the latest edition of Vision Voice.
Read MoreMDFA is Australia’s largest source of research funding in the field of macular disease outside of government.
Read MoreLeeloo, one of our dedicated Peer Support Facilitators, volunteers her time to helping build a space where people living with macular disease can connect and feel stronger.
Read More